Prospective Hyperthermia Database in Cancer Patients (HT Register)

Recruiting Observational Study
Hyperthermia Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Pirus Ghadjar · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This monocentric study registry records all cancer patients at the Charité which are treated with hyperthermia to examine the therapeutic use of hyperthermia in cancer patients in the general application and to obtain an accurate risk-benefit balance After confinement in this database are the patients prospectively in order to complications, disease status and survival status tracked. Furthermor…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Contrazeption with female patients at the capable of bearing children age * Written agreement is present (DvH, ICH-GCP) * Patients, who participate at the same time in a interventional study, can nevertheless in this register study participate if this none Exclusion criterion …
Contacts

Pirus Ghadjar, PD Dr.

+4930450657055

pirus.ghadjar@charite.de

CONTACT